Rhenman & Partners Asset Management AB as of March 31, 2022
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 89 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 3.5 | $35M | 124k | 286.37 | |
| Horizon Therapeutics Pub L SHS | 3.5 | $35M | 336k | 105.21 | |
| Abbvie (ABBV) | 3.1 | $32M | 195k | 162.11 | |
| UnitedHealth (UNH) | 2.9 | $30M | 58k | 509.97 | |
| McKesson Corporation (MCK) | 2.9 | $29M | 95k | 306.13 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.8 | $28M | 182k | 155.67 | |
| Pfizer (PFE) | 2.7 | $27M | 523k | 51.77 | |
| Cigna Corp (CI) | 2.6 | $27M | 112k | 239.61 | |
| CVS Caremark Corporation (CVS) | 2.3 | $24M | 235k | 101.21 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.3 | $23M | 90k | 260.97 | |
| Anthem (ELV) | 2.2 | $23M | 46k | 491.22 | |
| Boston Scientific Corporation (BSX) | 2.2 | $23M | 510k | 44.29 | |
| Abiomed | 2.2 | $23M | 68k | 331.24 | |
| Alnylam Pharmaceuticals (ALNY) | 2.1 | $21M | 130k | 163.29 | |
| Johnson & Johnson (JNJ) | 2.0 | $20M | 113k | 177.23 | |
| Regeneron Pharmaceuticals (REGN) | 2.0 | $20M | 29k | 698.42 | |
| Cooper Cos Com New | 1.9 | $19M | 46k | 417.59 | |
| Apellis Pharmaceuticals (APLS) | 1.9 | $19M | 377k | 50.81 | |
| Merck & Co (MRK) | 1.8 | $19M | 225k | 82.05 | |
| Medtronic SHS (MDT) | 1.8 | $18M | 160k | 110.95 | |
| Tenet Healthcare Corp Com New (THC) | 1.7 | $18M | 203k | 85.96 | |
| Intra Cellular Therapies (ITCI) | 1.7 | $17M | 280k | 61.19 | |
| BioMarin Pharmaceutical (BMRN) | 1.7 | $17M | 220k | 77.10 | |
| AmerisourceBergen (COR) | 1.6 | $17M | 108k | 154.71 | |
| Biohaven Pharmaceutical Holding | 1.6 | $16M | 136k | 118.57 | |
| Intuitive Surgical Com New (ISRG) | 1.6 | $16M | 53k | 301.68 | |
| Centene Corporation (CNC) | 1.6 | $16M | 187k | 84.19 | |
| Axonics Modulation Technolog (AXNX) | 1.5 | $15M | 240k | 62.60 | |
| Biontech Se Sponsored Ads (BNTX) | 1.4 | $15M | 85k | 170.56 | |
| Thermo Fisher Scientific (TMO) | 1.4 | $14M | 24k | 590.65 | |
| Align Technology (ALGN) | 1.3 | $13M | 30k | 436.00 | |
| Harmony Biosciences Hldgs In (HRMY) | 1.3 | $13M | 268k | 48.65 | |
| Mirati Therapeutics | 1.2 | $12M | 150k | 82.22 | |
| Inspire Med Sys (INSP) | 1.2 | $12M | 48k | 256.69 | |
| Becton, Dickinson and (BDX) | 1.2 | $12M | 45k | 266.00 | |
| Humana (HUM) | 1.1 | $12M | 27k | 435.17 | |
| Shockwave Med (SWAV) | 1.1 | $11M | 55k | 207.35 | |
| Cytokinetics Com New (CYTK) | 1.1 | $11M | 295k | 36.81 | |
| Abbott Laboratories (ABT) | 1.1 | $11M | 90k | 118.36 | |
| Privia Health Group (PRVA) | 1.0 | $11M | 398k | 26.73 | |
| Gilead Sciences (GILD) | 1.0 | $10M | 170k | 59.45 | |
| Danaher Corporation (DHR) | 1.0 | $10M | 34k | 293.32 | |
| Neurocrine Biosciences (NBIX) | 1.0 | $9.8M | 105k | 93.75 | |
| Xencor (XNCR) | 0.9 | $9.2M | 344k | 26.68 | |
| Seagen | 0.9 | $8.8M | 61k | 144.05 | |
| Veeva Sys Cl A Com (VEEV) | 0.8 | $8.1M | 38k | 212.45 | |
| Iovance Biotherapeutics (IOVA) | 0.8 | $7.9M | 475k | 16.65 | |
| Edwards Lifesciences (EW) | 0.8 | $7.7M | 65k | 117.72 | |
| R1 Rcm | 0.7 | $7.6M | 282k | 26.76 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.7 | $7.4M | 681k | 10.84 | |
| Meiragtx Holdings (MGTX) | 0.7 | $6.9M | 500k | 13.85 | |
| ImmunoGen | 0.7 | $6.8M | 1.4M | 4.76 | |
| Teladoc (TDOC) | 0.7 | $6.6M | 92k | 72.13 | |
| Guardant Health (GH) | 0.6 | $6.3M | 95k | 66.24 | |
| Silk Road Medical Inc Common (SILK) | 0.6 | $6.2M | 150k | 41.29 | |
| Glaukos (GKOS) | 0.6 | $6.1M | 105k | 57.82 | |
| Novocure Ord Shs (NVCR) | 0.6 | $5.8M | 70k | 82.86 | |
| Aerie Pharmaceuticals | 0.5 | $5.4M | 589k | 9.10 | |
| EXACT Sciences Corporation (EXAS) | 0.5 | $5.3M | 76k | 69.92 | |
| Progyny (PGNY) | 0.5 | $5.1M | 100k | 51.40 | |
| Immunocore Hldgs Ads (IMCR) | 0.5 | $5.1M | 171k | 29.90 | |
| Alkermes SHS (ALKS) | 0.5 | $4.7M | 180k | 26.31 | |
| Health Catalyst (HCAT) | 0.5 | $4.7M | 180k | 26.13 | |
| Esperion Therapeutics (ESPR) | 0.4 | $4.6M | 982k | 4.64 | |
| Goodrx Hldgs Com Cl A (GDRX) | 0.4 | $4.5M | 235k | 19.33 | |
| Sangamo Biosciences (SGMO) | 0.4 | $4.4M | 761k | 5.81 | |
| Iveric Bio | 0.4 | $4.4M | 260k | 16.83 | |
| 1life Healthcare | 0.4 | $4.2M | 375k | 11.08 | |
| Oak Street Health | 0.4 | $4.0M | 150k | 26.88 | |
| Revance Therapeutics (RVNC) | 0.4 | $3.9M | 198k | 19.50 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.4 | $3.8M | 1.3M | 2.99 | |
| Intellia Therapeutics (NTLA) | 0.4 | $3.6M | 50k | 72.68 | |
| Accolade (ACCD) | 0.3 | $3.5M | 200k | 17.56 | |
| Myovant Sciences | 0.3 | $3.3M | 249k | 13.32 | |
| Nektar Therapeutics (NKTR) | 0.3 | $3.3M | 614k | 5.39 | |
| Phathom Pharmaceuticals (PHAT) | 0.3 | $3.2M | 235k | 13.61 | |
| Biogen Idec (BIIB) | 0.3 | $3.2M | 15k | 210.60 | |
| Phreesia (PHR) | 0.3 | $3.1M | 117k | 26.36 | |
| Stereotaxis Com New (STXS) | 0.3 | $3.0M | 797k | 3.73 | |
| Viewray (VRAYQ) | 0.3 | $2.9M | 735k | 3.92 | |
| Ionis Pharmaceuticals (IONS) | 0.3 | $2.6M | 71k | 37.04 | |
| Essa Pharma Com New (EPIX) | 0.3 | $2.5M | 411k | 6.18 | |
| Macrogenics (MGNX) | 0.2 | $2.5M | 287k | 8.81 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 0.2 | $2.5M | 140k | 17.66 | |
| G1 Therapeutics (GTHX) | 0.2 | $2.4M | 316k | 7.60 | |
| Olema Pharmaceuticals (OLMA) | 0.2 | $2.1M | 500k | 4.26 | |
| Rapid Micro Biosystems Class A Com (RPID) | 0.2 | $2.0M | 300k | 6.79 | |
| Pieris Pharmaceuticals (PIRS) | 0.1 | $909k | 300k | 3.03 | |
| Annexon (ANNX) | 0.1 | $683k | 250k | 2.73 |
